RPE65-mediated inherited retinal disease

FDA embraces the first US application for a gene therapy, offering an accelerated test case
Endpoints
Mon, 07/17/17 - 09:59 am
FDA
gene therapy
Spark Therapeutics
Luxturna
RPE65-mediated inherited retinal disease